SCHEMBL9848539

SCHEMBL9848539

Nc1ccnc(-n2cccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
KMT2A Q03164 4/20 0.51
MAPT P10636 4/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
MEN1 O00255 3/20 0.51
MAPK1 P28482 1/20 0.50
MKNK1 Q9BUB5 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
HPGD P15428 4/20 0.45
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CDC7 O00311 1/20 0.42
KDM4E B2RXH2 4/20 0.39
OGA O60502 1/20 0.38
KDM1A O60341 1/20 0.37
HSP90AA1 P07900 1/20 0.37
POLB P06746 3/20 0.36
BLM P54132 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7593026 0.75 ALDH1A1 (0.60) ALDH1A1KMT2AMAPTL3MBTL1MEN1
SCHEMBL27904488 0.75 ADORA2A (0.47) ALDH1A1MAPTL3MBTL1MAPK1MKNK1
Hydrochloric Acid SCHEMBL28376383 0.73 ADORA2A (0.46) ALDH1A1MAPTL3MBTL1MAPK1MKNK1
SCHEMBL14844681 0.72 ADORA2A (0.47) KMT2AMEN1MKNK1MKNK2CDC7
SCHEMBL29097661 0.72 MKNK1 (0.43) MAPK1MKNK1MKNK2CDC7OGA
Hydrochloric Acid SCHEMBL28374859 0.72 ADORA2A (0.45) ALDH1A1MAPTL3MBTL1MAPK1MKNK1
Hydrochloric Acid SCHEMBL28375706 0.72 ADORA2A (0.45) ALDH1A1MAPTL3MBTL1MAPK1MKNK1
SCHEMBL3262365 0.71 MAPK1 (0.44) ALDH1A1KMT2AMAPTL3MBTL1MEN1
SCHEMBL18803631 0.71 MKNK1 (0.60) MAPTMKNK1MKNK2CDC7
SCHEMBL21568429 0.69 GRIN2D (0.47) MKNK1MKNK2KDM1APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135642-A Inhibitors of mutant forms of EGFR 缆图药品公司 2022-09-30 CN disclosed
EP-0417584-A2 N-substituted-4-pyrimidinamines and -pyrimidindiamines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-03-20 EP disclosed